• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[播散性红斑狼疮中的血栓形成]

[Thrombosis in disseminated lupus erythematosus].

作者信息

Bellucci S

出版信息

Phlebologie. 1986 Apr-Jun;39(2):459-63.

PMID:3749282
Abstract

In the course of disseminated lupus erythematosus (DLE), the development of arterial or venous thrombosis is sometimes observed. They are rare in the course of hematological forms of DLE, in which the more or less constant leucopenia is accompanied to variable extent by the affection of the other blood-lines: thrombocytopenia and/or thrombocytopathy and/or hemolytic anemia. The discovery of a circulating anticoagulant seems to be correlated with the existence of thrombosis. In fact it involves antiphospholipid antibodies, responsible for the protraction of certain coagulation tests, which shows up their existence. Recent studies have shown recognition of the membrane phospholipids of the vascular endothelial cell. A functional imbalance in this would be observed to encourage the synthesis of factors favorable to thrombosis.

摘要

在播散性红斑狼疮(DLE)病程中,有时会观察到动脉或静脉血栓形成。在血液学形式的DLE病程中它们较为罕见,在这种情况下,或多或少持续存在的白细胞减少症会在不同程度上伴有其他血细胞系的受累:血小板减少和/或血小板病和/或溶血性贫血。循环抗凝剂的发现似乎与血栓形成的存在相关。事实上,它涉及抗磷脂抗体,这些抗体导致某些凝血试验延长,从而显示出它们的存在。最近的研究表明血管内皮细胞膜磷脂的识别。观察到其中的功能失衡会促进有利于血栓形成的因子的合成。

相似文献

1
[Thrombosis in disseminated lupus erythematosus].[播散性红斑狼疮中的血栓形成]
Phlebologie. 1986 Apr-Jun;39(2):459-63.
2
Antiphospholipid antibodies: an elderly statesman Dons new garments.抗磷脂抗体:一位元老披上了新衣。
J Rheumatol Suppl. 1987 Jun;14 Suppl 13:208-13.
3
Antiphospholipid antibodies: risk factors or only markers for thrombosis, fetal loss and thrombocytopenia?
Neth J Med. 1990 Apr;36(3-4):177-81.
4
The antiphospholipid syndrome: the clot thickens.抗磷脂综合征:血栓愈发严重。
J Ky Med Assoc. 1992 Jan;90(1):11-7.
5
[Antiphospholipid antibodies: specificity and mechanism of action].[抗磷脂抗体:特异性及作用机制]
Ann Med Interne (Paris). 1990;141(3):257-60.
6
[The role of anti-phospholipid antibodies in the development of thrombotic complications and in obstetrical pathology].[抗磷脂抗体在血栓形成并发症及产科病理发展中的作用]
Klin Med (Mosk). 1989 Jun;67(6):59-64.
7
Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.狼疮抗凝物是系统性红斑狼疮患者发生静脉和动脉血栓形成的最强风险因素。不同抗磷脂抗体检测方法的比较。
Thromb Haemost. 1996 Dec;76(6):916-24.
8
[Clinical value of determining the levels of lupus anticoagulant and anti-cardiolipin antibodies].[检测狼疮抗凝物及抗心磷脂抗体水平的临床价值]
Ter Arkh. 1988;60(7):84-7.
9
Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.系统性红斑狼疮或原发性抗磷脂综合征患者中抗凝血酶原抗体的患病率及临床意义
Haematologica. 2000 Jun;85(6):632-7.
10
[Chorea and systemic lupus erythematosus with circulating anticoagulant. 3 cases].[伴有循环抗凝物质的舞蹈病与系统性红斑狼疮。3例]
Rev Neurol (Paris). 1985;141(8-9):571-7.